Form 4 for HCWB HCW Biologics Inc.
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001209191-24-003787 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | 2024-02-20 | HCWB | Wong Hing C | CEO, Dir | A - Grant | $1.40 | +739.3K | 16.05M | +5% | +$1.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | A | A | 739,288 | $1.40 | 16,054,156 | D | — | — |